REVUE NEUROLOGIQUE

Scope & Guideline

Advancing Neurological Science with Every Issue

Introduction

Welcome to your portal for understanding REVUE NEUROLOGIQUE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageFrench
ISSN0035-3787
PublisherMASSON EDITEUR
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1946 to 1947, from 1950 to 1961, from 1963 to 2024
AbbreviationREV NEUROL-FRANCE / Rev. Neurol.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE

Aims and Scopes

The REVUE NEUROLOGIQUE is dedicated to advancing knowledge in the field of neurology, with a focus on clinical, epidemiological, and therapeutic aspects of neurological disorders. Its scope encompasses a wide range of topics, reflecting the complexity and diversity of neurological conditions and their management.
  1. Clinical Neurology:
    The journal emphasizes clinical research, presenting studies that evaluate diagnostic methods, treatment efficacy, and the management of various neurological disorders.
  2. Neurogenetics and Biomarkers:
    Research focusing on genetic factors and biomarkers associated with neurological diseases is a key area, enhancing our understanding of disease mechanisms and potential therapeutic targets.
  3. Neuroimaging and Neuropathology:
    The use of advanced imaging techniques and neuropathological studies to diagnose and understand neurological disorders is frequently explored, providing insights into disease progression and treatment outcomes.
  4. Neuropsychology and Cognitive Function:
    The journal publishes studies on the cognitive and psychological aspects of neurological conditions, examining how these disorders impact mental health and quality of life.
  5. Innovative Therapies and Interventions:
    A focus on novel treatment approaches, including pharmacological, surgical, and rehabilitative strategies, is evident, highlighting the journal's commitment to improving patient outcomes.
  6. Public Health and Epidemiology:
    The REVUE NEUROLOGIQUE also addresses the epidemiological aspects of neurological diseases, contributing to a better understanding of their prevalence, risk factors, and public health implications.
The REVUE NEUROLOGIQUE has increasingly focused on several emerging themes that reflect the current priorities and advancements in the field of neurology. These trends highlight the journal's responsiveness to new challenges and innovations in neurological research.
  1. Neuroimmunology and Autoimmune Disorders:
    An increasing number of studies focus on neuroimmunological conditions, such as autoimmune encephalitis and myasthenia gravis, reflecting a growing interest in the interplay between the immune system and neurological health.
  2. Neurodegeneration and Aging:
    Research on neurodegenerative diseases, particularly in the context of aging populations, is on the rise, emphasizing the need for effective management strategies and interventions.
  3. Digital Health and Telemedicine:
    The COVID-19 pandemic has accelerated the adoption of digital health technologies and telemedicine in neurology, leading to a surge in studies evaluating their effectiveness and implementation.
  4. Neurotechnology and Therapeutic Innovations:
    There is a notable trend towards exploring innovative neurotechnological interventions, including neuromodulation techniques and gene therapies, aimed at improving patient outcomes.
  5. Psychiatric Comorbidities in Neurological Disorders:
    Research examining the relationship between neurological conditions and psychiatric disorders, such as depression and anxiety, is gaining traction, reflecting a holistic approach to patient care.

Declining or Waning

While the REVUE NEUROLOGIQUE continues to publish a wide array of topics in neurology, certain themes have become less prominent in recent years, reflecting shifts in research priorities and emerging areas of interest.
  1. Classical Neurological Syndromes:
    There has been a noticeable decline in publications focusing on classical neurological syndromes that were once staples of neurology literature, possibly due to a shift towards more contemporary issues such as neurogenetics and advanced imaging.
  2. Historical and Biographical Studies:
    Research centered on the historical aspects of neurology and biographical studies of notable figures in the field has decreased, as the focus shifts towards current clinical and experimental findings.
  3. General Neurological Education:
    Papers solely focused on general education in neurology or basic clinical practices are becoming less common, indicating a trend towards more specialized and research-driven content.
  4. Traditional Pharmacological Approaches:
    There appears to be a waning interest in traditional pharmacological approaches, as newer therapeutic strategies and personalized medicine gain prominence in the field.

Similar Journals

Acta Epileptologica

Elevating knowledge in clinical neurology.
Publisher: SPRINGERNATUREISSN: 2096-9384Frequency: 1 issue/year

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

BEHAVIOURAL NEUROLOGY

Pioneering Research: Shaping the Future of Behavioral Neurology
Publisher: HINDAWI LTDISSN: 0953-4180Frequency: 1 issue/year

BEHAVIOURAL NEUROLOGY is a distinguished open-access journal published by Hindawi Ltd, dedicated to advancing the field of neurology and neuropsychology since its inception in 1988. With ISSN: 0953-4180 and E-ISSN: 1875-8584, this journal provides a platform for innovative research and interdisciplinary studies that explore the intricate connections between behavior and neurological processes. Housed in the Netherlands, BEHAVIOURAL NEUROLOGY enjoys a commendable reputation, boasting impressive quartile rankings of Q2 in various medical and psychological categories, reflecting its significant contribution to the literature with a focus on clinical neurology and physiological psychology. The journal's rigorous peer-review process ensures that published works meet high academic standards, making it an essential resource for researchers, clinicians, and students seeking to deepen their understanding of neurological disorders and cognitive function. As of 2023, it ranks in the 80th percentile in neuropsychology, further underscoring its impact and relevance in the scientific community. For those interested in accessible knowledge, BEHAVIOURAL NEUROLOGY's commitment to open access facilitates the dissemination of groundbreaking research, allowing a wider audience to engage with critical advancements in the field.

ACTA NEUROLOGICA BELGICA

Empowering Knowledge, Transforming Neurology.
Publisher: SPRINGER HEIDELBERGISSN: 0300-9009Frequency: 4 issues/year

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

NEUROPEDIATRICS

Shaping the future of child neurology through rigorous scholarship.
Publisher: GEORG THIEME VERLAG KGISSN: 0174-304XFrequency: 6 issues/year

NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.

NEUROLOGIC CLINICS

Elevating understanding through rigorous research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Neurology Research International

Fostering Global Collaboration in Neurology
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

Multiple Sclerosis International

Elevating discourse, shaping the future of multiple sclerosis research.
Publisher: HINDAWI LTDISSN: 2090-2654Frequency:

Multiple Sclerosis International is a leading open-access journal dedicated to advancing the scientific understanding of multiple sclerosis (MS) and related neurological disorders. Published by HINDAWI LTD since 2010, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality peer-reviewed articles that cover a diverse range of topics, including epidemiology, treatment strategies, and the latest advancements in MS research. With its commitment to open access, Multiple Sclerosis International ensures that critical findings are readily available to the global community, fostering collaborative efforts to improve patient outcomes and advance therapeutic approaches. The journal not only enhances scholarly discourse in the field but also significantly impacts clinical practices by presenting cutting-edge research and insights.

JOURNAL OF NEUROLOGY

Advancing the frontiers of neurological research.
Publisher: SPRINGER HEIDELBERGISSN: 0340-5354Frequency: 12 issues/year

The Journal of Neurology, published by Springer Heidelberg, stands as a distinguished platform within the realm of neurology, encompassing both fundamental and clinical aspects of the field. With an impressive impact factor and notable rankings—43rd out of 400 in clinical neurology and 22nd out of 192 in neuroscience—this journal consistently showcases high-quality research and groundbreaking studies. Established in 1974, it has evolved over nearly half a century to adapt to the latest advancements, maintaining its Q1 quartile ranking for both neurology and clinical neurology in 2023. With an extensive scope that includes original research, reviews, and case reports, the journal fosters knowledge dissemination and engages a global audience of researchers, clinicians, and students. Although it does not currently offer open access options, its rigorous peer-reviewed publication process ensures that only the most impactful studies contribute to the understanding and advancement of neurological sciences.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Advancing Neural Restoration: Pioneering Research in Neurology and Neuroscience
Publisher: IOS PRESSISSN: 0922-6028Frequency: 6 issues/year

RESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.

EUROPEAN NEUROLOGY

Transforming Neurological Knowledge into Clinical Practice
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.